Document:

Exhibit 10.1

 

SUBSCRIPTION AGREEMENT

 

THIS SUBSCRIPTION AGREEMENT (this “Agreement”),
dated as of September __, 2016, by and among Eastside Distilling, Inc., a Nevada corporation (the “Company”),
and the subscribers identified on the signature page hereto (each a “Subscriber” and collectively “Subscribers”).

 

WHEREAS, the Company and the Subscribers
are executing and delivering this Agreement in reliance upon an exemption from securities registration afforded by the provisions
of Section 4(a)(2), Section 4(6) and/or Regulation D (“Regulation D”) as promulgated by the United States Securities
and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended (the “1933
Act”).

 

WHEREAS, the parties desire that, upon
the terms and subject to the conditions contained herein, the Company shall issue and sell to the Subscribers, as provided herein,
and the Subscribers, in the aggregate, shall purchase up to One Million Five Hundred Thousand Dollars ($1,500,000) (the “Purchase
Price”) of principal amount of promissory notes of the Company (“Note” or “Notes”),
a form of which is annexed hereto as Exhibit A, and share purchase warrants (the “Warrants”), in the
form annexed hereto as Exhibits B, to purchase up to Fifteen Million (15,000,000) shares of the Company’s common stock,
par value $0.0001 per shares (the “Warrant Shares”). The Notes, the Warrants, and the Warrant Shares are collectively
referred to herein as the “Securities.”

 

NOW, THEREFORE, in consideration of the
mutual covenants and other agreements contained in this Agreement the Company and the Subscribers hereby agree as follows:

 

1.          Conditions
To Closing. Subject to the satisfaction or waiver of the terms and conditions of this Agreement, on the Closing Date (as defined
in Section 2), each Subscriber shall purchase, and the Company shall sell to each Subscriber, a Note in the principal amount designated
on the signature page hereto. The aggregate amount of the Notes to be purchased by the Subscribers on the Closing Date shall, in
the aggregate, be equal to the Purchase Price.

 

2.          Closing
Date. The “Closing Date” shall be the date that Subscriber funds representing the amount due the Company
from the Purchase Price of the offer and sale of the Notes and Warrants is transmitted by wire transfer or otherwise to or for
the benefit of the Company. The consummation of the transactions contemplated herein for all Closings shall take place at the offices
of the Company, 1805 SE Martin Luther King Jr. Blvd. Portland, Oregon 97214, upon the satisfaction of all conditions to Closing
set forth in this Agreement.

 

3.          Warrants.         On
the Closing Date, the Company will issue and deliver a Warrant to each Subscriber. The number of Warrant Shares underlying each
Warrant will be equal to the principal amount of the Note subscribed for by Subscriber multiplied by ten (10) (the “Warrant
Shares”). The Exercise Price to acquire a Warrant Share will be $0.10. The Warrants shall be exercisable until three (3)
years after the Closing Date.

 

    1 

     

    

 

4.          Subscriber’s
Representations and Warranties. Each Subscriber hereby represents and warrants to and agrees with the Company only as to such
Subscriber the following:

 

(a)          Organization
and Standing of the Subscribers. If the Subscriber is an entity, such Subscriber is a corporation, limited liability company,
partnership, or other entity duly incorporated or organized, validly existing and in good standing under the laws of the jurisdiction
of its incorporation or organization.

 

(b)          Authorization
and Power. Each Subscriber has the requisite power and authority to enter into and perform this Agreement and the Security
Agreement and to purchase the Notes and Warrants being sold to it hereunder. The execution, delivery and performance of this Agreement
and the Security Agreement by such Subscriber and the consummation by it of the transactions contemplated hereby and thereby have
been duly authorized by all necessary corporate or partnership action, and no further consent or authorization of such Subscriber
or its Board of Directors, stockholders, partners, members, as the case may be, is required. This Agreement has been duly authorized,
executed, and delivered by such Subscriber and constitutes, or shall constitute when executed and delivered, a valid and binding
obligation of the Subscriber enforceable against the Subscriber in accordance with the terms thereof.

 

(c)          Information
on Company. The Subscriber has been furnished with or has had access at the EDGAR Website of the Commission to the Company’s
Form 10-K for the year ended December 31, 2015 and all periodic and other reports as filed with the Commission subsequent thereto
(hereinafter referred to as the “Reports”). In addition, the Subscriber has received in writing from the Company
such other information concerning its operations, financial condition and other matters as the Subscriber has requested in writing
(such other information is collectively, the “Other Written Information”), and considered all factors the Subscriber
deems material in deciding on the advisability of investing in the Securities.

 

(e)          Information
on Subscriber. The Subscriber is, and will be at the time of the exercise of the Warrants, an “accredited investor”,
as such term is defined in Regulation D promulgated by the Commission under the 1933 Act, is experienced in investments and business
matters, has made investments of a speculative nature and has purchased securities of United States publicly-owned companies in
private placements in the past and, with its representatives, has such knowledge and experience in financial, tax and other business
matters as to enable the Subscriber to utilize the information made available by the Company to evaluate the merits and risks of
and to make an informed investment decision with respect to the proposed purchase, which represents a speculative investment. The
Subscriber has the authority and is duly and legally qualified to purchase and own the Securities. The Subscriber is able to bear
the risk of such investment for an indefinite period and to afford a complete loss thereof. The information set forth on the signature
page hereto regarding the Subscriber is accurate.

 

(f)          Purchase
of Notes and Warrants. On the Closing Date, the Subscriber will purchase the Notes and Warrants as principal for its own account
for investment only and not with a view toward, or for resale in connection with, the public sale or any distribution thereof.

 

    2 

     

    

 

(g)          Compliance
with Securities Act. The Subscriber understands and agrees that the Securities have not been registered under the 1933 Act
or any applicable state securities laws, by reason of their issuance in a transaction that does not require registration under
the 1933 Act (based in part on the accuracy of the representations and warranties of Subscriber contained herein), and that such
Securities must be held indefinitely unless a subsequent disposition is registered under the 1933 Act or any applicable state securities
laws or is exempt from such registration.

 

(h)          Note
Legend. The Note shall bear the following or similar legend:

 

“THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES
ACT OF 1933, AS AMENDED. THIS NOTE MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION
STATEMENT AS TO THIS NOTE UNDER SAID ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO [THE COMPANY] THAT SUCH REGISTRATION
IS NOT REQUIRED.”

 

(i)          Warrants
Legend. The Warrants shall bear the following or similar legend:

 

“THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON
EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS WARRANT AND THE COMMON SHARES
ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE
REGISTRATION STATEMENT AS TO THIS WARRANT UNDER SAID ACT OR ANY APPLICABLE STATE SECURITIES LAW OR AN OPINION OF COUNSEL REASONABLY
SATISFACTORY TO [THE COMPANY] THAT SUCH REGISTRATION IS NOT REQUIRED.”

 

(j)          Warrant
Shares Legend. The Warrant Shares shall bear the following legend:

 

“THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT
BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THESE SHARES MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED
IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH SECURITIES ACT OR ANY APPLICABLE STATE SECURITIES LAW OR AN OPINION
OF COUNSEL REASONABLY SATISFACTORY TO [THE COMPANY] THAT SUCH REGISTRATION IS NOT REQUIRED.”

 

    3 

     

    

 

(k)          Communication
of Offer. The offer to sell the Securities was directly communicated to the Subscriber by the Company. At no time was the Subscriber
presented with or solicited by any leaflet, newspaper or magazine article, radio or television advertisement, or any other form
of general advertising or solicited or invited to attend a promotional meeting otherwise than in connection and concurrently with
such communicated offer.

 

(l)          Authority;
Enforceability. This Agreement and other agreements delivered together with this Agreement or in connection herewith have been
duly authorized, executed and delivered by the Subscriber and are valid and binding agreements enforceable in accordance with their
terms, subject to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and similar laws of general applicability
relating to or affecting creditors’ rights generally and to general principles of equity; and Subscriber has full corporate
power and authority necessary to enter into this Agreement and such other agreements and to perform its obligations hereunder and
under all other agreements entered into by the Subscriber relating hereto.

 

(m)          Restricted
Securities. Subscriber understands that the Securities have not been registered under the 1933 Act and such Subscriber will
not sell, offer to sell, assign, pledge, hypothecate or otherwise transfer any of the Securities unless pursuant to an effective
registration statement under the 1933 Act.

 

(n)          No
Governmental Review. Each Subscriber understands that no United States federal or state agency or any other governmental or
state agency has passed on or made recommendations or endorsement of the Securities or the suitability of the investment in the
Securities, nor have such authorities passed upon or endorsed the merits of the offering of the Securities.

 

5.          Company
Representations and Warranties. The Company represents and warrants to and agrees with each Subscriber the following, except
as set forth in the Reports and as otherwise qualified in the Transaction Documents:

 

(a)          Due
Incorporation. The Company is a corporation duly organized, validly existing, and in good standing under the laws of the jurisdiction
of its incorporation and has the requisite corporate power to own its properties and to carry on its business is disclosed in the
Reports. The Company does not have any subsidiaries.

 

(b)          Authority;
Enforceability. This Agreement, the Notes, the Warrants, and any other agreements delivered together with this Agreement or
in connection herewith (collectively “Transaction Documents”) have been duly authorized, executed and delivered
by the Company and are valid and binding agreements enforceable in accordance with their terms, subject to bankruptcy, insolvency,
fraudulent transfer, reorganization, moratorium and similar laws of general applicability relating to or affecting creditors’
rights generally and to general principles of equity. The Company has full corporate power and authority necessary to enter into
and deliver the Transaction Documents and to perform its obligations thereunder.

 

(c)          Consents.
No consent, approval, authorization, or order of any court, governmental agency or body or arbitrator having jurisdiction over
the Company, or any of its Affiliates, any Principal Market, or the Company’s stockholders is required for the execution
by the Company of the Transaction Documents and compliance and performance by the Company of its obligations under the Transaction
Documents, including, without limitation, the issuance and sale of the Securities.

 

    4 

     

    

 

(e)          No
Violation or Conflict. Assuming the representations and warranties of the Subscribers in Section 4 are true and correct, neither
the issuance and sale of the Securities nor the performance of the Company’s obligations under this Agreement and the Transaction
Documents will violate, conflict with, result in a breach of, or constitute a default (or an event which with the giving of notice
or the lapse of time or both would be reasonably likely to constitute a default in any material respect) of a material nature under
(A) the articles or certificate of incorporation, charter or bylaws of the Company or (B) to the Company’s knowledge, any
decree, judgment, order, law, treaty, rule, regulation or determination applicable to the Company of any court, governmental agency
or body, or arbitrator having jurisdiction over the Company or over the properties or assets of the Company.

 

(f)          The
Securities. The Securities upon issuance:

 

(i)          have
been, or will be, duly and validly authorized, and upon exercise of the Warrants, the Warrant Shares will be duly and validly issued,
fully paid and nonassessable, and, if (A) registered pursuant to the 1933 Act, (B) prospectus delivery requirements have been complied
with, and (C) resold pursuant to an effective registration statement, will be free trading and unrestricted;

 

(ii)         except
as set forth in Schedule 5(f) will not have been issued or sold in violation of any preemptive or other similar rights of
the holders of any securities of the Company;

 

(iii)        will
not result in a violation of Section 5 under the 1933 Act, provided Subscriber’s representations herein are true and accurate
and Subscribers take no actions or fail to take any actions required by Subscriber for Subscriber’s purchase of the Securities
to be in compliance with all applicable laws and regulations.

 

(g)          Litigation.
There is no pending or, to the best knowledge of the Company, threatened action, suit, proceeding or investigation before any court,
governmental agency or body, or arbitrator having jurisdiction over the Company, or any of its Affiliates that would affect the
execution by the Company or the performance by the Company of its obligations under the Transaction Documents. Except as disclosed
in the Reports, there is no pending or, to the best knowledge of the Company, basis for or threatened action, suit, proceeding
or investigation before any court, governmental agency or body, or arbitrator having jurisdiction over the Company, or any of its
Affiliates which litigation if adversely determined would have a Material Adverse Effect.

 

(h)          Defaults.
The Company is not in violation of its articles of incorporation or bylaws. Except as disclosed on Schedule 5(h), the Company
is (i) not in material default under or in material violation of any other material agreement or instrument to which it is a party
or by which it or any of its properties are bound or affected, which default or violation would have a Material Adverse Effect,
(ii) not in default with respect to any order of any court, arbitrator or governmental body or subject to or party to any order
of any court or governmental authority arising out of any action, suit or proceeding under any statute or other law respecting
antitrust, monopoly, restraint of trade, unfair competition or similar matters, or (iii) to the Company’s knowledge, not
in violation of any statute, rule or regulation of any governmental authority which violation would have a Material Adverse Effect.
For purpose of this Agreement, a “Material Adverse
Effect” shall mean a material adverse effect on the financial condition, results of operations, properties or business of
the Company taken as a whole.

 

    5 

     

    

 

(i)          Title
to Assets, Trademarks, Patents. The Company has good and clear record and marketable title in fee to such of its fixed assets
as are real property, and good and merchantable title to all of its other assets, now carried on its books including those reflected
in the most recent balance sheet of the Company or acquired since the date of such balance sheet free of any mortgages, pledges,
charges, liens, security interests or other encumbrances, except as set forth on Schedule 5(i). The Company enjoys peaceful
and undisturbed possession under all leases under which it is operating, and all said leases are valid and subsisting and in full
force and effect. The Company owns or has a valid right to use the patents, patent rights, licenses, permits, trade secrets, trademarks,
trademark rights, trade names or trade name rights or franchises, copyrights, inventions and intellectual property rights being
used to conduct its business as now operated and as now proposed to be operated; and the conduct of its business as now operated
and as now proposed to be operated does not and will not conflict with valid patents, patent rights, licenses, permits, trade secrets,
trademarks, trademark rights, trade names or trade name rights or franchises, copyrights, inventions and intellectual property
rights of others.

 

(j)          Insurance.
The Company carries insurance covering its properties and business adequate and customary for the type and scope of the properties
and business, but in any event in amounts sufficient to prevent the Company from becoming a co-insurer.

 

(k)          Books
and Records. The books of account, ledgers, order books, records and documents of the Company accurately and completely reflect,
in all material respects, all material information relating to the business of the Company, the nature, acquisition, maintenance,
location and collection of the assets of the Company, and the nature of all transactions giving rise to the obligations or accounts
receivable of the Company.

 

(j)          No
General Solicitation. Neither the Company, nor any of its Affiliates, nor to its knowledge, any person acting on its or their
behalf, has engaged in any form of general solicitation or general advertising (within the meaning of Regulation D under the 1933
Act) in connection with the offer or sale of the Securities.

 

6.          Regulation
D Offering. The offer and issuance of the Securities to the Subscribers is being made pursuant to the exemption from the registration
provisions of the 1933 Act afforded by Section 4(a)(2) or Section 4(6) of the 1933 Act and/or Rule 506 of Regulation D promulgated
thereunder. The Company will provide, at the Company’s expense, such other legal opinions in the future as are reasonably
necessary for the issuance and resale of the Common Stock issuable upon conversion of the Notes and exercise of the Warrants pursuant
to an effective registration statement.

 

7.          Miscellaneous.

 

(a)          Notices.
All notices, demands, requests, consents, approvals, and other communications required or permitted hereunder shall be in writing
and, unless otherwise specified herein, shall be (i) personally served, (ii) deposited in the mail, registered or certified, return
receipt requested, postage prepaid, (iii) delivered by reputable air courier service with charges prepaid, or (iv) transmitted
by hand delivery, telegram, or facsimile, addressed as set forth below or to such other address as such party shall have specified
most recently by written notice. Any notice or other communication required or permitted to be given hereunder shall be deemed
effective (a) upon hand delivery or delivery by email or facsimile, with accurate confirmation generated by the transmitting email
or facsimile machine, at the address or number designated below (if delivered on a business day during normal business hours where
such notice is to be received), or the first business day following such delivery (if delivered other than on a business day during
normal business hours where such notice is to be received) or (b) on the second business day following the date of mailing by
express courier service, fully prepaid, addressed to such address, or upon actual receipt of such mailing, whichever shall first
occur. The addresses for such communications shall be: (i) if to the Company, to: Eastside Distilling, Inc., 1805 SE Martin Luther
King Jr. Blvd. Portland, Oregon 97214, Attn: Steven Earles, email: steven@eastsidedistilliing.com and (ii) if to the Subscriber,
to: the one or more addresses and telecopier numbers or email addresses indicated on the signature pages hereto.

 

    6 

     

    

 

(b)          Entire
Agreement; Assignment. This Agreement and other documents delivered in connection herewith represent the entire agreement between
the parties hereto with respect to the subject matter hereof and may be amended only by a writing executed by both parties. Neither
the Company nor the Subscribers have relied on any representations not contained or referred to in this Agreement and the documents
delivered herewith. No right or obligation of the Company shall be assigned without prior notice to and the written consent of
the Subscribers.

 

(c)          Amendments,
Waivers and Consents. Any provision in this Agreement the Notes to the contrary notwithstanding, changes in or additions to
this Agreement may be made, and compliance with any covenant or provision herein or therein set forth may be omitted or waived,
if the Company (i) shall obtain consent thereto in writing from the holder or holders of at least seventy-five percent (75%) in
principal amount of all Notes then outstanding, and (ii) shall, in each case, deliver copies of such consent in writing to any
holders who did not execute the same; provided that no such consent shall be effective to reduce or to postpone the date fixed
for the payment of the principal (including any required redemption) or interest payable on any Note, without the consent of the
holder thereof, or to reduce the percentage of the Notes the consent of the holders of which is required under this Section. Any
waiver or consent may be given subject to satisfaction of conditions stated therein and any waiver or consent shall be effective
only in the specific instance and for the specific purpose for which given. Written notice of any waiver or consent effected under
this subsection shall promptly be delivered by the Company to any holders who did not execute the same. 

 

(d)          Counterparts/Execution.
This Agreement may be executed in any number of counterparts and by the different signatories hereto on separate counterparts,
each of which, when so executed, shall be deemed an original, but all such counterparts shall constitute but one and the same instrument.
This Agreement may be executed by facsimile signature and delivered by facsimile transmission.

 

    7 

     

    

 

(e)          Law
Governing this Agreement. This Agreement shall be governed by and construed in accordance with the laws of the State of Nevada
without regard to conflicts of laws principles that would result in the application of the substantive laws of another jurisdiction.
Any action brought by either party against the other concerning the transactions contemplated by this Agreement shall be brought
only in the civil or state courts of Oregon or in the federal courts located in Multnomah County. The parties and the individuals
executing this Agreement and other agreements referred to herein or delivered in connection herewith on behalf of the Company agree
to submit to the jurisdiction of such courts and waive trial by jury. The prevailing party shall be entitled to recover from
the other party its reasonable attorney’s fees and costs. In the event that any provision of this Agreement or any other
agreement delivered in connection herewith is invalid or unenforceable under any applicable statute or rule of law, then such provision
shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to conform with such statute
or rule of law. Any such provision which may prove invalid or unenforceable under any law shall not affect the validity or enforceability
of any other provision of any agreement.

 

(f)          Reimbursement
of Expenses. The Company agrees to reimburse any Subscriber for its out-of-pocket expenses, including the fees and expenses
of its counsel, in connection with the enforcement of this Agreement, the Notes or any of the Transaction Documents.

 

(g)          Specific
Enforcement. The Company and Subscriber acknowledge and agree that irreparable damage would occur in the event that any of
the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly
agreed that the parties shall be entitled to one or more preliminary and final injunctions to prevent or cure breaches of the provisions
of this Agreement and to enforce specifically the terms and provisions hereof, this being in addition to any other remedy to which
any of them may be entitled by law or equity.

    8 

     

    

 

(h)          Independent
Nature of Subscribers.     The Company acknowledges that the obligations of each Subscriber under the Transaction
Documents are several and not joint with the obligations of any other Subscriber, and no Subscriber shall be responsible in any
way for the performance of the obligations of any other Subscriber under the Transaction Documents. The Company acknowledges that
each Subscriber has represented that the decision of each Subscriber to purchase Securities has been made by such Subscriber independently
of any other Subscriber and independently of any information, materials, statements or opinions as to the business, affairs, operations,
assets, properties, liabilities, results of operations, condition (financial or otherwise) or prospects of the Company which may
have been made or given by any other Subscriber or by any agent or employee of any other Subscriber, and no Subscriber or any of
its agents or employees shall have any liability to any Subscriber (or any other person) relating to or arising from any such information,
materials, statements or opinions.  The Company acknowledges that nothing contained in any Transaction Document, and no action
taken by any Subscriber pursuant hereto or thereto shall be deemed to constitute the Subscribers as a partnership, an association,
a joint venture or any other kind of entity, or create a presumption that the Subscribers are in any way acting in concert or as
a group with respect to such obligations or the transactions contemplated by the Transaction Documents.  The Company acknowledges
that each Subscriber shall be entitled to independently protect and enforce its rights, including without limitation, the rights
arising out of the Transaction Documents, and it shall not be necessary for any other Subscriber to be joined as an additional
party in any proceeding for such purpose.  The Company acknowledges that it has elected to provide all Subscribers with the
same terms and Transaction Documents for the convenience of the Company and not because Company was required or requested to do
so by the Subscribers.  The Company acknowledges that such procedure with respect to the Transaction Documents in no way creates
a presumption that the Subscribers are in any way acting in concert or as a group with respect to the Transaction Documents or
the transactions contemplated thereby.

 

[THIS SPACE INTENTIONALLY LEFT BLANK]

    9 

     

    

Signature Page for Individuals:

 

IN WITNESS WHEREOF, Subscriber
has caused this Subscription Agreement to be executed as of the date indicated below.

 

	$_______________________________	 	 
	Total Purchase Price (Amount of Note)	 	 
	 	 	 
	Print or Type Name	 	Print or Type Name (Joint-owner)
	 	 	 
	Signature	 	Signature (Joint-owner)
	 	 	 
	Date	 	Date (Joint-owner)
	 	 	 
	IRS Taxpayer Identification Number	 	IRS Taxpayer Identification Number (Joint-owner)
	 	 	 
	Address	 	Address (Joint-owner)
	 	 	 
	Telephone Number	 	Telephone Number
	 	 	 
	Fax Number	 	Fax Number
	 	 	 
	E-mail Address	 	E-mail Address

 

Type of Ownership

 

	 	 ̈	Individual
	⁭	 ̈	Tenants in common
	⁭	 ̈	Joint tenants with right of survivorship
	⁭	 ̈	Community property (check only if resident of community property state)
	⁭	 ̈	Other (please specify:____________________)

 

    10 

     

    

 

Wiring Instructions:

 

Bank Name: 

ABA: 

SWIFT: 

Tel Number: 

Address: 

Acct #: 

Acct. Name: 

Reference: 

 

    11 

     

    

 

Partnerships, Corporations or Other Entities:

 

IN WITNESS WHEREOF, Subscriber
has caused this Subscription Agreement to be executed as of the date indicated below.

 

$ _____________________________________

Total Purchase Price       (Amount of Note)      

 

_____________________________________________________________________________

Print or Type Name of Entity

______________________________________________________________________________

Address

 

______________________________

Telephone Number

 

______________________________

Fax Number

 

______________________________

Email Address

 

	 	 	 
	Taxpayer I.D. No. (if applicable)	 	Date
	 	 	 
	By:	 	 	 
	Signature:	 Name:	 	Print or Type Name and Indicate
	 	Title:	 	 Title or Position with Entity
	 	 	 
	 	 	 
	Signature (other authorized signatory)	 	Print or Type Name and Indicate
	 	 	Title or Position with Entity

 

Type of Ownership

 

	 	 ̈⁭	Corporation
	⁭	 ̈	Limited Liability Company
	⁭	 ̈	Partnership
	⁭	 ̈	Trust
	⁭	 ̈	Other (please specify:____________________)

 

    12 

     

    

 

All subscriptions from partnerships, corporations,
trusts or limited liability companies must be accompanied by resolutions of the appropriate corporate authority (board of directors,
trustee or managing partner or members, as applicable) and trust documents evidencing the authorization and power to make the subscription.

 

Wiring Instructions:

 

Bank Name:

ABA:

SWIFT:

Tel Number: 

Address: 

Acct #: 

Acct. Name: 

Reference: 

 

    13 

     

    

 

SUBSCRIPTION ACCEPTANCE BY EASTSIDE DISTILLING
INC.

 

IN WITNESS WHEREOF, the
Company has caused this Subscription Agreement to be executed, and the foregoing subscription accepted, as of the date indicated
below.

 

	 	Eastside Distilling, Inc.
	 	 	 
	 	By:	 
	 	Name:	 
	 	Title:	 

 

Date: ____________, 2016

 

    14Exhibit

FIRST AMENDMENT TO CONSULTING AGREEMENT

This FIRST AMENDMENT TO CONSULTING AGREEMENT (this "Amendment") is entered into as of September 21, 2016, by and among Alexion Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and Dr. Leonard Bell, M.D. ("Dr. Bell").

WHEREAS, the Company and Dr. Bell entered into a Consulting Agreement, dated as of April 1, 2015 (the "Agreement");

WHEREAS, capitalized terms used herein and not defined herein shall have the meaning set forth in the Agreement; and

WHEREAS, the parties desire to amend the Agreement to extend the term of the Agreement by six months with an option to extend the term for an additional six months.  

NOW, THEREFORE, in consideration of the foregoing and the respective covenants and agreements set forth below, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and Dr. Bell hereby agree as follows:

		
	1.
	Term. Notwithstanding anything express or implied to the contrary set forth in Section 1 of the Agreement, the Consulting Period will be extended until March 31, 2017, unless not later than thirty (30) days prior to such date the Consulting Period is further extended for an additional six (6) months by mutual agreement of Dr. Bell and the Company’s Chief Executive Officer and approved by the Board of Directors of the Company, or is earlier terminated as provided in the Agreement, as amended hereby.

		
	2.
	Compensation.  The Consulting Fee for the period beginning on October 1, 2016 and ending on March 31, 2017 shall be $750,000.  If the Consulting Period is extended by the parties in accordance with the provisions of Section 1 of this Amendment, the Consulting Fee for the period beginning on April 1, 2017 and ending on September 30, 2017 will be $750,000, unless otherwise agreed between the parties.  

		
	3.
	Agreement. Except as modified by this Amendment, the Agreement is in all other respects hereby ratified and confirmed.

		
	4.
	Choice of Law.  The validity, interpretation, construction and performance of this Amendment will be governed by the laws of the State of Connecticut, without giving effect to the principles of conflict of laws.  

		
	5.
	Severability.  If one or more provisions of this Amendment are held to be unenforceable under applicable law, such portion will be deemed to be modified or altered to the extent necessary to conform thereto or, if that is not possible, to be omitted from this Amendment.  The invalidity of any such portion will not affect the force, effect, and validity of the remaining portion hereof.

		
	6.
	Counterparts.  This Amendment may be executed in counterparts, each of which will be deemed an original, but all of which together will constitute one and the same instrument.

-1-

This Amendment has been executed by the Company, by its duly authorized representative, and by Dr. Bell as of the date first written above. The Company affirms that this Amendment has been duly authorized by its Board. 

ALEXION PHARMACEUTICALS, INC.

By: /s/ David Hallal 

Title:  Chief Executive Officer

LEONARD BELL, M.D.

/s/ Leonard Bell
Signature

-2-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00262-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00262-of-00352.parquet"}]]